New hope for lymphoma patients: experimental drug combo enters human trials
Disease control
Not yet recruiting
This early-phase study tests a new drug (rocbrutinib) combined with standard chemotherapy for people with a type of blood cancer (diffuse large B-cell lymphoma) that has come back or not responded to prior treatment. The main goal is to find a safe dose and check for side effects…
Phase: PHASE1 • Sponsor: Guangzhou Lupeng Pharmaceutical Company LTD. • Aim: Disease control
Last updated May 17, 2026 04:34 UTC